Understanding and managing cardiac side-effects of second-generation antipsychotics in the treatment of schizophrenia
Abstract
SUMMARY Second-generation antipsychotic medications (SGAs) have advanced the treatment of schizophrenia over the past 30 years. However, a number of potentially life-threatening cardiac side-effects associated with these treatments concern and can discourage prescribers from administering these evidence-based treatments. This review provides a practical, psychiatrist-oriented understanding of the relative frequencies, mechanisms, investigations...
Paper Details
Title
Understanding and managing cardiac side-effects of second-generation antipsychotics in the treatment of schizophrenia
Published Date
Sep 11, 2019
Journal
Volume
26
Issue
1
Pages
26 - 40
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History